• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AT1和AT2受体在成年心肌细胞中血管紧张素II对丝裂原活化蛋白激酶和丝裂原活化蛋白激酶磷酸酶-1的调节作用。

Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes.

作者信息

Fischer T A, Singh K, O'Hara D S, Kaye D M, Kelly R A

机构信息

Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Am J Physiol. 1998 Sep;275(3):H906-16. doi: 10.1152/ajpheart.1998.275.3.H906.

DOI:10.1152/ajpheart.1998.275.3.H906
PMID:9724295
Abstract

ANG II has been implicated in the hypertrophic response in ventricular myocytes by acting at the angiotensin type 1 (AT1) receptor. However, the role of the angiotensin type 2 (AT2) receptor in the adult heart is not as clearly understood. In adult rat ventricular myocytes (ARVM) and cardiac microvascular endothelial cells (CMEC), we examined the role of ANG II signaling, via AT1 and AT2 receptors, on the activation of the extracellular signal-regulated protein kinases (ERKs) and on the expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1. ANG II caused no detectable increase in ERK activity or in c-fos mRNA abundance in ARVM but increased ERK activity within 5 min in CMEC and increased c-fos mRNA levels. However, in the presence of the selective phosphoprotein phosphatase (PP-2A/PP-1) inhibitor okadaic acid (OA), a sustained increase in ERK activity, as well as in c-jun NH2-terminal protein kinase activity, in ARVM was observed. ANG II increased MKP-1 mRNA levels within 15 min in ARVM and CMEC. In contrast to the response in endothelial cells, however, ANG II activation of MKP-1 in ARVM was mediated by AT2-receptor activation. Thus there is constitutive as well as inducible suppression of ERKs and c-jun NH2-terminal protein kinases by MKP and PP-2A/PP-1 in the adult cardiac myocyte phenotype.

摘要

血管紧张素II(ANG II)通过作用于1型血管紧张素(AT1)受体,参与心室肌细胞的肥大反应。然而,2型血管紧张素(AT2)受体在成体心脏中的作用尚不清楚。在成年大鼠心室肌细胞(ARVM)和心脏微血管内皮细胞(CMEC)中,我们研究了ANG II通过AT1和AT2受体信号传导对细胞外信号调节蛋白激酶(ERK)激活以及丝裂原活化蛋白激酶(MAPK)磷酸酶MKP-1表达的作用。ANG II未引起ARVM中ERK活性或c-fos mRNA丰度的可检测增加,但在CMEC中5分钟内增加了ERK活性,并增加了c-fos mRNA水平。然而,在存在选择性磷蛋白磷酸酶(PP-2A/PP-1)抑制剂冈田酸(OA)的情况下,观察到ARVM中ERK活性以及c-jun NH2末端蛋白激酶活性持续增加。ANG II在ARVM和CMEC中15分钟内增加了MKP-1 mRNA水平。然而,与内皮细胞中的反应不同,ANG II在ARVM中对MKP-1的激活是由AT2受体激活介导的。因此,在成年心肌细胞表型中,MKP和PP-2A/PP-1对ERK和c-jun NH2末端蛋白激酶存在组成性和诱导性抑制作用。

相似文献

1
Role of AT1 and AT2 receptors in regulation of MAPKs and MKP-1 by ANG II in adult cardiac myocytes.AT1和AT2受体在成年心肌细胞中血管紧张素II对丝裂原活化蛋白激酶和丝裂原活化蛋白激酶磷酸酶-1的调节作用。
Am J Physiol. 1998 Sep;275(3):H906-16. doi: 10.1152/ajpheart.1998.275.3.H906.
2
Two distinct mechanisms of angiotensin II-induced negative regulation of the mitogen-activated protein kinases in cultured cardiac myocytes.血管紧张素II诱导培养心肌细胞中丝裂原活化蛋白激酶负调控的两种不同机制。
Hypertens Res. 2001 Jul;24(4):385-94. doi: 10.1291/hypres.24.385.
3
Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase.血管紧张素II 2型受体介导对丝裂原活化蛋白激酶级联反应的抑制及SHP-1酪氨酸磷酸酶的功能激活。
Biochem J. 1997 Jul 15;325 ( Pt 2)(Pt 2):449-54. doi: 10.1042/bj3250449.
4
Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-Jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: evidence from vascular-targeted transgenic mice of AT2 receptor.血管紧张素II 2型受体通过SHP-1酪氨酸磷酸酶活性对酪氨酸激酶Pyk2和c-Jun氨基末端激酶的影响:来自血管靶向AT2受体转基因小鼠的证据。
Biochem Biophys Res Commun. 2001 Apr 20;282(5):1085-91. doi: 10.1006/bbrc.2001.4695.
5
Estrogen activates phosphatases and antagonizes growth-promoting effect of angiotensin II.雌激素激活磷酸酶并拮抗血管紧张素II的促生长作用。
Hypertension. 2002 Jan;39(1):41-5. doi: 10.1161/hy1201.097197.
6
[MKP-1 regulates the cardiomyocyte hypertrophic responses induced by angiotensin II].[丝裂原活化蛋白激酶磷酸酶-1调节血管紧张素II诱导的心肌细胞肥大反应]
Sheng Li Xue Bao. 2000 Oct;52(5):365-70.
7
Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell.酪氨酸磷酸酶SHP-1在大鼠胎儿血管平滑肌细胞中AT2受体介导的细胞凋亡中的关键作用。
Cardiovasc Res. 2001 Mar;49(4):863-71. doi: 10.1016/s0008-6363(00)00299-6.
8
LPS regulate ERK1/2-dependent signaling in cardiac fibroblasts via PKC-mediated MKP-1 induction.脂多糖通过蛋白激酶C介导的丝裂原活化蛋白激酶磷酸酶-1诱导作用来调节心肌成纤维细胞中依赖细胞外信号调节激酶1/2的信号传导。
Biochem Biophys Res Commun. 2003 Mar 28;303(1):74-80. doi: 10.1016/s0006-291x(03)00301-2.
9
Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases.腺病毒介导的猪心脏成纤维细胞中人类血管紧张素II 2型受体的过表达和刺激,不会调节细胞增殖、I型胶原蛋白mRNA表达及ERK1/ERK2活性,但会抑制蛋白酪氨酸磷酸酶。
J Mol Med (Berl). 2001 Sep;79(9):510-21. doi: 10.1007/s001090100243.
10
Mitogen-activated protein kinase phosphatase 1 inhibits the stimulation of gene expression by hypertrophic agonists in cardiac myocytes.丝裂原活化蛋白激酶磷酸酶1抑制心肌细胞中肥大激动剂对基因表达的刺激作用。
Biochem J. 1997 Apr 15;323 ( Pt 2)(Pt 2):313-9. doi: 10.1042/bj3230313.

引用本文的文献

1
The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.血管紧张素 AT 受体:从结合位点到新的治疗靶点。
Pharmacol Rev. 2022 Oct;74(4):1051-1135. doi: 10.1124/pharmrev.120.000281.
2
Class A and C GPCR Dimers in Neurodegenerative Diseases.A 类和 C 类 G 蛋白偶联受体二聚体在神经退行性疾病中的作用。
Curr Neuropharmacol. 2022;20(11):2081-2141. doi: 10.2174/1570159X20666220327221830.
3
Angiotensin Type 2 Receptors: Painful, or Not?2型血管紧张素受体:会引发疼痛吗?
Front Pharmacol. 2020 Dec 23;11:571994. doi: 10.3389/fphar.2020.571994. eCollection 2020.
4
Combined Angiotensin Receptor Modulation in the Management of Cardio-Metabolic Disorders.联合血管紧张素受体调节在心血管代谢紊乱管理中的应用
Drugs. 2016 Jan;76(1):1-12. doi: 10.1007/s40265-015-0509-4.
5
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].国际基础与临床药理学联合会。XCIX. 血管紧张素受体:病理生理血管紧张素能刺激的解读器[校正后]
Pharmacol Rev. 2015 Oct;67(4):754-819. doi: 10.1124/pr.114.010454.
6
New developments in the pharmacological treatment of hypertension: dead-end or a glimmer at the horizon?高血压药物治疗的新进展:死胡同还是曙光初现?
Curr Hypertens Rep. 2015 Jun;17(6):557. doi: 10.1007/s11906-015-0557-x.
7
AT2 receptor activities and pathophysiological implications.AT2受体活性及其病理生理学意义。
J Cardiovasc Pharmacol. 2015 Mar;65(3):226-32. doi: 10.1097/FJC.0000000000000208.
8
AT(2) receptor and tissue injury: therapeutic implications.AT2 受体与组织损伤:治疗意义。
Curr Hypertens Rep. 2014 Feb;16(2):416. doi: 10.1007/s11906-013-0416-6.
9
Angiotensin II type-2 receptor-specific effects on the cardiovascular system.血管紧张素 II 型受体对心血管系统的特异性作用。
Cardiovasc Diagn Ther. 2012 Mar;2(1):56-62. doi: 10.3978/j.issn.2223-3652.2012.02.02.
10
How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations?血管紧张素 AT(2) 受体激活如何帮助神经元分化并改善神经元病变情况?
Front Endocrinol (Lausanne). 2012 Dec 19;3:164. doi: 10.3389/fendo.2012.00164. eCollection 2012.